In fact, our recent study showed that high expression of miR-224 is associated with poor prognosis in lung ADC patients having kras/p53 mutations; however, we found no association between miR-224 expressions and NSCLC patients' overall survival. This evidence concerns the gene KRAS and non-small cell lung carcinoma.